Back to Trials
NCT04962815Recruiting

Ceribell Delirium Data Collection Study

Ceribell Inc.

Start Date

11/10/2021

Completion Date

4/1/2026

Summary

This study is designed as a prospective, non-randomized, observational clinical study. The study will collect clinical and rrEEG (Ceribell EEG) data when monitoring subjects for delirium subtypes. EEG and clinical data will be collected for the development of future software algorithms to assess the presence and severity of delirium.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: All must be present * Age is 18 years or older * Admitted to the Intensive Care Unit (ICU) * Subject must be fluent in the language in which the delirium assessment is performed Exclusion Criteria: All must be absent \- Any condition that prevents use of the Ceribell EEG system on the subject for the entire anticipated EEG monitoring period. Examples may include: Craniectomy with missing bone flap in an area where Ceribell EEG electrodes are placed. Expected use of continuous clinical EEG for the entire anticipated monitoring period.

Interventions

DEVICE

Electroencephalogram (EEG) Test

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Delirium

Locations

Stanford University

Stanford, California 94305

United States

Naples Community Hospital

Naples, Florida 34102

United States

University of Iowa Hospitals & Clinics

Iowa City, Iowa 52242

United States

Mercy

St Louis, Missouri 63141

United States

Cooper Health

Camden, New Jersey 08103

United States

UNC Health Rex

Raleigh, North Carolina 27607

United States

University of Pittsburgh

Pittsburgh, Pennsylvania 15213

United States